Lessee, Operating Lease, Liability, to be Paid, Year Four in GBP of TC BioPharm (Holdings) plc from Q4 2023 to Q4 2024

Taxonomy & unit
us-gaap: GBP
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
TC BioPharm (Holdings) plc quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four history and change rate from Q4 2023 to Q4 2024.
  • TC BioPharm (Holdings) plc Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2024 was £447K, unchanged year-over-year.
Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (GBP)
Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

TC BioPharm (Holdings) plc Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (GBP)

Period Value YoY Chg Change % Date Report Filed
Q4 2024 447K 0 0% 31 Dec 2024 20-F 09 May 2025
Q2 2024 447K 30 Jun 2024 6-K 25 Nov 2024
Q1 2024 447K 31 Mar 2024 10-Q 15 May 2024
Q4 2023 447K 31 Dec 2023 10-K 01 Apr 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.